Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FLUTAMIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 671 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Klotz, L
      Combined androgen blockade in prostate cancer: meta-analyses and associated issues

      BJU INTERNATIONAL
    2. Iversen, P; Melezinek, I; Schmidt, A
      Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function

      BJU INTERNATIONAL
    3. Console, GM; Jurado, SB; Rulli, SB; Calandra, RS; Dumm, CLAG
      Ultrastructural and quantitative immunohistochemical changes induced by nonsteroid antiandrogens on pituitary gonadotroph population of prepubertal male rats

      CELLS TISSUES ORGANS
    4. Niopas, I; Daftsios, AC
      Determination of 2-hydroxyflutamide in human plasma by high-performance liquid chromatography and its application to pharmacokinetic studies

      JOURNAL OF CHROMATOGRAPHY B
    5. Eri, LM; Tveter, KJ
      Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA),acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)

      PROSTATE CANCER AND PROSTATIC DISEASES
    6. Foster, PMD; Mylchreest, E; Gaido, KW; Sar, M
      Effects of phthalate esters on the developing reproductive tract of male rats

      HUMAN REPRODUCTION UPDATE
    7. Moghetti, P
      Advances in the treatment of polycystic ovary syndrome

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    8. Harris, KA; Small, EJ
      Hormonal treatment for prostate cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    9. Glemain, P
      Dangers of subgroup analyses and multiple tests

      PROGRES EN UROLOGIE
    10. Cortes, MG; Andrade, RJ; Lucena, MI; Martinez, HS; Fernandez, MC; Ferrer, T; Martin-Vivaldi, R; Pelaez, G; Suarez, F; Rosemary-Gomez, M; Montero, JL; Fraga, E; Camargo, R; Alcantara, R; Pizarro, MA; Garcia-Ruiz, E
      Flutamide-induced hepatotoxicity: report of a case series

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    11. McIntyre, BS; Barlow, NJ; Foster, PMD
      Androgen-mediated development in male rat offspring exposed to flutamide in utero: Permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues

      TOXICOLOGICAL SCIENCES
    12. Schulz, M; Schmoldt, A; Donn, F; Becker, H
      Lack of methemoglobinemia with flutamide

      ANNALS OF PHARMACOTHERAPY
    13. Sawaya, ME
      Regulation of the human hair cycle

      CURRENT PROBLEMS IN DERMATOLOGY-US
    14. Kraus, I; Vitezic, D; Oguic, R
      Flutamide-induced acute hepatitis in advanced prostate cancer patients

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    15. Saika, T; Kusaka, N; Tsushima, T; Yamato, T; Ohashi, T; Suyama, B; Arata, R; Nasu, Y; Kumon, H
      Treatment of androgen-independent prostate cancer with dexamethasone: A prospective study in stage D2 patients

      INTERNATIONAL JOURNAL OF UROLOGY
    16. Foster, PMD; Mylchreest, E; Gaido, KW; Sar, M
      Effects of phthalate esters on the developing reproductive tract of male rats

      APMIS
    17. Tekur, S; Lau, KM; Long, J; Burnstein, K; Ho, SM
      Expression of RFG/ELE1 alpha/ARA70 in normal and malignant prostatic epithelial cell cultures and lines: Regulation by methylation and sex steroids

      MOLECULAR CARCINOGENESIS
    18. Yamasaki, K; Sawaki, M; Takatsuki, M
      Strain sensitivity differences in the Hershberger assay

      REPRODUCTIVE TOXICOLOGY
    19. Ema, M; Miyawaki, E
      Adverse effects on development of the reproductive system in male offspring of rats given monobutyl phthalate, a metabolite of dibutyl phthalate, during late pregnancy

      REPRODUCTIVE TOXICOLOGY
    20. Barth, JH
      Rational investigations in the diagnosis and management of women with hirsutism or androgenetic alopecia

      CLINICS IN DERMATOLOGY
    21. Laszlo, FA; Toth, S; Kocsis, J; Pavo, I; Szecsi, M
      Testosterone-secreting gonadotropin-responsive adrenal adenoma and its treatment with the antiandrogen flutamide

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    22. Caplea, A; Seachrist, D; Dunphy, G; Ely, D
      Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    23. Andrews, P; Freyberger, A; Hartmann, E; Eiben, R; Loof, I; Schmidt, U; Temerowski, M; Becka, M
      Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide

      ARCHIVES OF TOXICOLOGY
    24. Lanigan, SW
      Management of unwanted hair in females

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    25. Nunez-Vergara, LJ; Farias, D; Bollo, S; Squella, JA
      An electrochemical evidence of free radicals formation from flutamide and its reactivity with endo/xenobiotics of pharmacological relevance

      BIOELECTROCHEMISTRY
    26. Tan, A; Tuckey, A; Rice, M
      Orchidectomy following failure of antiandrogen monotherapy in patients with metastatic prostate cancer

      EUROPEAN UROLOGY
    27. Iversen, P; Abrahamsson, PA; Mulders, PFA
      Advanced prostate cancer

      EUROPEAN UROLOGY
    28. Caldiroli, M; Cova, V; Lovisolo, JA; Reali, L; Bono, AV
      Antiandrogen withdrawal in the treatment of hormone-relapsed prostate cancer: Single institutional experience

      EUROPEAN UROLOGY
    29. Dundar, M; Kocak, I; Culhaci, N
      A new experimental model for cryptorchidism: inguinoscrotal approach

      UROLOGICAL RESEARCH
    30. Nellemann, C; Vinggaard, AM; Dalgaard, M; Hossaini, A; Larsen, JJ
      Quantification of antiandrogen effect determined by Lightcycler technology

      TOXICOLOGY
    31. Stein, S; Zoltick, B; Peacock, T; Holroyde, C; Haller, D; Armstead, B; Malkowicz, SB; Vaughn, DJ
      Phase II trial of toremifene in androgen-independent prostate cancer - A Penn cancer clinical trials group trial

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    32. Collette, L; Studer, UE; Schroder, FH; Denis, LJ; Sylvester, RJ
      Why phase III trials of maximal androgen blockade versus castration in M-1prostate cancer rarely show statistically significant differences

      PROSTATE
    33. McKinnell, C; Atanassova, N; Williams, K; Fisher, JS; Walker, M; Turner, KJ; Saunders, PTK; Sharpe, RM
      Suppression of androgen action and the induction of gross abnormalities ofthe reproductive tract in male rats treated neonatally with diethylstilbestrol

      JOURNAL OF ANDROLOGY
    34. Imajima, T; Shono, T; Kai, H; Zakaria, O; Suita, S
      The biological effect of phthalate esters on transabdominal migration of the testis in fetal rats in comparison with the antiandrogen flutamide

      PEDIATRIC SURGERY INTERNATIONAL
    35. Salyer, DL; Lund, TD; Fleming, DE; Lephart, ED; Horvath, TL
      Sexual dimorphism and aromatase in the rat retina

      DEVELOPMENTAL BRAIN RESEARCH
    36. Carmina, E
      A risk-benefit assessment of pharmacological therapies for hirsutism

      DRUG SAFETY
    37. Copur, MS; Ledakis, P; Lynch, J; Hauke, R; Tarantolo, S; Bolton, M; Norvell, M; Muhvic, J; Hake, L; Wendt, J
      Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer

      SEMINARS IN ONCOLOGY
    38. Baatrup, E; Junge, M
      Antiandrogenic pesticides disrupt sexual characteristics in the adult maleguppy (Poecilia reticulata)

      ENVIRONMENTAL HEALTH PERSPECTIVES
    39. Schellhammer, PF
      Luteinizing hormone-releasing hormone monotherapy: A viable option for treatment of prostate cancer?

      UROLOGY
    40. Kolvenbag, GJCM; Iversen, P; Newling, DWW
      Antiandrogen monotherapy: A new form of treatment for patients with prostate cancer

      UROLOGY
    41. Stricker, HJ
      Luteinizing hormone-releasing hormone antagonists in prostate cancer

      UROLOGY
    42. Grossfeld, GD; Small, EJ; Lubeck, DP; Latini, D; Broering, JM; Carroll, PR
      Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy

      UROLOGY
    43. Schmitt, B; Wilt, TJ; Schellhammer, PF; DeMasi, V; Sartor, O; Crawford, ED; Bennett, CL
      Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: A systematic review

      UROLOGY
    44. Tsushima, T; Nasu, Y; Saika, T; Maki, Y; Noda, M; Suyama, B; Yamato, T; Kumon, H
      Optimal starting time for flutamide to prevent disease flare in prostate cancer patients treated with a gonadotropin-releasing hormone agonist

      UROLOGIA INTERNATIONALIS
    45. Nishimura, K; Nonomura, N; Ono, Y; Nozawa, M; Fukui, T; Harada, Y; Imazu, T; Takaha, N; Sugao, H; Miki, T; Okuyama, A
      Oral combination of cyclophosphamide, uracil plus tegafur and estramustinefor hormone-refractory prostate cancer

      ONCOLOGY
    46. Bondy, SJ; Iscoe, NA; Rothwell, DM; Gort, EH; Fleshner, NE; Paszat, LF; Browman, GP
      Trends in hormonal management of prostate cancer: A population-based studyin Ontario

      MEDICAL CARE
    47. Tomaszycki, ML; Davis, JE; Gouzoules, H; Wallen, K
      Sex differences in infant rhesus macaque separation-rejection vocalizations and effects of prenatal androgens

      HORMONES AND BEHAVIOR
    48. Kunte, C; Wolff, H
      New developments in the treatment of hypertrichosis

      HAUTARZT
    49. Cabeza, M; Heuze, I; Bratoeff, E; Murillo, E; Ramirez, E; Lira, A
      New progesterone esters as 5 alpha-reductase inhibitors

      CHEMICAL & PHARMACEUTICAL BULLETIN
    50. Demers, RY; Tiwari, A; Wei, J; Weiss, LK; Severson, RK; Montie, J
      Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality

      CANCER
    51. Naghdi, N; Nafisy, N; Majlessi, N
      The effects of intrahippocampal testosterone and flutamide on spatial localization in the Morris water maze

      BRAIN RESEARCH
    52. Paul, R; Alschibaja, M; von Randenborgh, H; Hartung, R; Breul, J
      Neoadjuvant hormonal therapy for localized prostate cancer prior to curative radical prostatectomy - Advantage or disadvantage?

      AKTUELLE UROLOGIE
    53. Hendershot, S; Koharski, D
      Appropriate column configurations for the rapid analysis and semipreparative purification of the radiolabeled drug flutamide by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY A
    54. Denis, LJ; Griffiths, K
      Endocrine treatment in prostate cancer

      SEMINARS IN SURGICAL ONCOLOGY
    55. Labrie, F
      Screening and hormonal therapy of localized prostate cancer shows major benefits on survival

      CANCER JOURNAL
    56. Wang, J; Halford, S; Rigg, A; Roylance, R; Lynch, M; Waxman, J
      Adjuvant mitozantrone chemotherapy in advanced prostate cancer

      BJU INTERNATIONAL
    57. Fitzpatrick, JM
      New developments in the pharmacological management of prostate cancer

      BJU INTERNATIONAL
    58. Asteinza, J; Camacho-Carranza, R; Reyes-Reyes, RE; Dorado-Gonzalez, V; Espinosa-Aguirre, JJ
      Induction of cytochrome P450 enzymes by albendazole treatment in the rat

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    59. Newling, DWW
      Maximum androgen blockade: a case study report

      PROSTATE CANCER AND PROSTATIC DISEASES
    60. Sepp-Lorenzino, L; Slovin, S
      Prostate cancer: therapeutic patent review

      EXPERT OPINION ON THERAPEUTIC PATENTS
    61. Kaisary, AV
      Patient-clinician choice in palliation of metastatic prostate cancer

      DRUGS & AGING
    62. Greenway, BA
      Androgen receptor-blocking agents - Potential role in pancreatic cancer

      DRUGS & AGING
    63. Gomez, SJR; Moreno, JM; Arribas, MIM; Villoria, AP; Higuera, CD; Gonzalez, AB
      Fulminant hepatic failure associated with flutamide.

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    64. Lambright, C; Ostby, J; Bobseine, K; Wilson, V; Hotchkiss, AK; Mann, PC; Gray, LE
      Cellular and molecular mechanisms of action of linuron: An antiandrogenic herbicide that produces reproductive malformations in male rats

      TOXICOLOGICAL SCIENCES
    65. Wolf, CJ; LeBlanc, GA; Ostby, JS; Gray, LE
      Characterization of the period of sensitivity of fetal male sexual development to vinclozolin

      TOXICOLOGICAL SCIENCES
    66. Williams, TM; Cattley, RC; Borghoff, SJ
      Alterations in endocrine responses in male Sprague-Dawley rats following oral administration of methyl tert-butyl ether

      TOXICOLOGICAL SCIENCES
    67. Yamada, T; Kunimatsu, T; Sako, H; Yabushita, S; Sukata, T; Okuno, Y; Matsuo, M
      Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity

      TOXICOLOGICAL SCIENCES
    68. Moul, JW
      Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy

      MOLECULAR UROLOGY
    69. White, RD
      Present and future management of prostate cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    70. Gatalica, Z; Norris, BA; Kovatich, AJ
      Immunohistochemical localization of prostate-specific antigen in ductal epithelium of male breast - Potential diagnostic pitfall in patients with gynecomastia

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    71. Vargas, F; Rivas, C; Mendez, H; Fuentes, A; Fraile, G; Velasquez, M
      Photochemistry and phototoxicity studies of flutamide, a phototoxic anti-cancer drug

      JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
    72. De Leo, V; Fulghesu, AM; la Marca, A; Morgante, G; Pasqui, L; Talluri, B; Torricelli, M; Caruso, A
      Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism

      GYNECOLOGICAL ENDOCRINOLOGY
    73. Muderris, II; Bayram, F; Guven, M
      Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)

      GYNECOLOGICAL ENDOCRINOLOGY
    74. Martelli, A; Campart, GB; Carrozzino, R; Ghia, M; Mattioli, F; Mereto, E; Orsi, P; Puglia, CP
      Evaluation of flutamide genotoxicity in rats and in primary human hepatocytes

      PHARMACOLOGY & TOXICOLOGY
    75. Dobson, CC; Reid, O; Bennett, NK; McDonald, SW
      Effect of vasectomy on the seminiferous tubule boundary zone in the AlbinoSwiss rat

      CLINICAL ANATOMY
    76. Hernandez-Tristan, R; Cerezo, AL
      Antihormonal treatment during early development affects sexual function and behavior in male rats

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    77. Dreicer, R
      The evolving role of hormone therapy in advanced prostate cancer

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    78. Baker, LH; Bahnson, RR; Hanks, GE; Huben, RP; Kantoff, P; Kozlowski, JM; Kuettel, M; Lange, PH; Logothetis, C; Pow-Sang, JM; Roach, M; Sandler, H; Scardino, PT; Taylor, RJ; Urban, DA; Walsh, PC; Wilson, TG
      NCCN Practice Guidelines for prostate cancer

      ONCOLOGY-NEW YORK
    79. Sawaya, ME; Shapiro, J
      Alopecia: Unapproved treatments or indications

      CLINICS IN DERMATOLOGY
    80. Kasimis, B; Wilding, G; Kreis, W; Feuerman, M; Chang, V; Hwang, S; Steafather, H; Cogswell, J; Rae, C; Blumenfrucht, M
      Survival of patients who had salvage castration after failure on bicalutamide monotherapy for stage (D-2) prostate cancer

      CANCER INVESTIGATION
    81. Klein, E; Drecier, R
      Reducing toxicity of hormonal therapy for prostate cancer

      CANCER INVESTIGATION
    82. Sawaya, ME; Shapiro, J
      Androgenetic alopecia - New and approved and unapproved treatments

      DERMATOLOGIC CLINICS
    83. Small, EJ; Meyer, M; Marshall, ME; Reyno, LM; Meyers, FJ; Natale, RB; Lenehan, PF; Chen, L; Slichenmyer, WJ; Eisenberger, M
      Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone

      JOURNAL OF CLINICAL ONCOLOGY
    84. Hussain, M; Fisher, EI; Petrylak, DP; O'Connor, J; Wood, DP; Small, EJ; Eisenberger, MA; Crawford, ED
      Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A southwest oncology group study

      JOURNAL OF CLINICAL ONCOLOGY
    85. Nagaraja, P; Sunitha, KR; Silwadi, MF
      New spectrophotometric method for the determination of flutamide in pharmaceutical preparations

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    86. Gheiler, EL; Tiguert, R
      Current concepts in androgen deprivation therapy - is there a "best" endocrine treatment?

      WORLD JOURNAL OF UROLOGY
    87. Sintov, A; Serafimovich, S; Gilhar, A
      New topical antiandrogenic formulations can stimulate hair growth in humanbald scalp grafted onto mice

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    88. Ozono, S; Okajima, E; Yamaguchi, A; Yoshikawa, M; Iwai, A; Moriya, A; Yoshida, K; Samma, S; Maruyama, Y; Hirao, Y
      A prospective randomized multicenter study of chlormadinone acetate versusflutamide in total androgen blockade for prostate cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    89. Akaza, H; Homma, Y; Okada, K; Yokoyama, M; Moriyama, N; Usami, M; Hirao, Y; Tsushima, T; Ohashi, Y; Aso, Y
      Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: A prospective and randomized study

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    90. Egawa, S; Takashima, R; Matsumoto, K; Mizoguchi, H; Kuwao, S; Baba, S
      A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    91. Zaccheo, T; Giudici, D; Panzeri, A; di Salle, E
      Combined treatment of Dunning R3327 rat prostatic tumor with the 5 alpha-reductase inhibitor PNU 157706 and the antiandrogen bicalutamide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    92. Toyoda, K; Shibutani, M; Tamura, T; Koujitani, T; Uneyama, C; Hirose, M
      Repeated dose (28 days) oral toxicity study of flutamide in rats, based onthe draft protocol for the 'Enhanced OECD Test Guideline 407' for screening for endocrine-disrupting chemicals

      ARCHIVES OF TOXICOLOGY
    93. Schulman, CC; Debruyne, FMJ; Forster, G; Selvaggi, FP; Zlotta, AR; Witjes, WPJ
      4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer

      EUROPEAN UROLOGY
    94. Kollerman, J; Feek, U; Muller, H; Kaulfuss, U; Oehler, U; Helpap, B; Kollermann, MW
      Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma

      EUROPEAN UROLOGY
    95. Tyrrell, CJ; Altwein, JE; Klippel, F; Jurincic-Winkler, C; Varenhorst, E; Lunglmayr, G; Boccardo, F; Holdaway, IM; Haefliger, JM; Jordaan, JP
      Comparison of an LH-RH analogue (Goeserelin Acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: Final survival results of an international multicentre randomized-trial

      EUROPEAN UROLOGY
    96. Fujikawa, K; Matsui, Y; Fukuzawa, S; Takeuchi, H
      Prostate-specific antigen levels and clinical response to flutamide as thesecond hormone therapy for hormone-refractory prostate carcinoma

      EUROPEAN UROLOGY
    97. del Vecchio, MT; Tripodi, SA; Arcuri, F; Pergola, L; Hako, L; Vatti, R; Cintorino, M
      Macrophage migration inhibitory factor in prostatic adenocarcinoma: Correlation with tumor grading and combination endocrine treatment-related changes

      PROSTATE
    98. Hedlund, PO
      Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens

      PROSTATE
    99. Griffiths, K; Denis, LJ
      Exploitable mechanisms for the blockade of androgenic action

      PROSTATE
    100. Kishi, H; Itoh, M; Wada, S; Yukinari, Y; Tanaka, Y; Nagamine, N; Jin, WZ; Watanabe, G; Taya, K
      Inhibin is an important factor in the regulation of FSH secretion in the adult male hamster

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/04/20 alle ore 13:48:22